Guest guest Posted July 28, 2006 Report Share Posted July 28, 2006 The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org – All the items listed below are on our front page: **Hepatitis C Journal Review: July 25, 2006 Volume 3, Issue 12 This issue: Hepatitis C in Patients Older Than 65 Low Doses of Peg-Intron Neutropenia and Infections in People with Hepatitis C Beliefs about Hepatitis C and Lifestyle Changes http://www.hcvadvocate.org/news/newsRev/2006/HJR-3.12.html **Hepatitis C Treatments in Current Clinical Development – Updated July 25 http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html **HCV ADVOCATE WEEKLY NEWS REVIEW: A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights Week Ending: July 22nd, 2006 http://www.hcvadvocate.org/news/newsRev/2006/NewsRev-162.html Lawmakers Override Veto of Syringe Law High Skin Cancer Risk Seen in Transplant Patients Noninvasive Method to Identify Fibrosis in Chronic Hep C CuraGen Begins Phase I/II Trial for Inoperable Hepatocellular Cancer Drug Two-In-One Hepatitis B Test Approved Low CD4 Cell Count and Hepatitis C Coinfection Risk Factors for Acute Kidney Failure in HIV-Infected Patients Tainted Blood Victims Not Ready to Celebrate BC Launches North America’s First Program to Reimburse Living Donors AVI BioPharma Announces Hepatitis C Virus Clinical Study Modification Study to Explore Drug-Use Options New Laser Test Screens for Hepatitis B Chronic Hepatitis C Interferon Response Predicted by Liver Protein Expression Safe Drug Sites Lauded Cancer Incidence Much Higher in People with Hep B or C Needle May Have Contaminated Inmates British Doctors Issue Cancer Warning over Chinese Liver Tonic Sincerely, Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.